year 17, Issue 6 (November - December 2023)                   Iran J Med Microbiol 2023, 17(6): 663-668 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

F. Faruq Z, Khalaf Jabar S. Molecular Study of Porphyromonas Gingivalis Strains With fimA Genotypes in Periodontitis Patients. Iran J Med Microbiol 2023; 17 (6) :663-668
URL: http://ijmm.ir/article-1-2046-en.html
1- Department of Biology, College of Science, University of Misan, Misan, Iraq
2- Department of Anatomy, College of Medicine, University of Misan, Misan, Iraq , Sami_khalaf2006@yahoo.com
Full-Text [PDF 538 kb]   (116 Downloads)     |   Abstract (HTML)  (419 Views)
Full-Text:   (34 Views)
Introduction


It is thought that at least 700 different bacterial species exist. The gingival sulcus is the area of the oral mucosa that has been the subject of most research in this field. The gingival sulcus, which lies between the gingiva and the tooth's hard surface, is home to the microbial populations that communicate with mucosal epithelial cells (1). Dental biofilms are formed by interacting bacteria with this area and the formation of layers on the living and nonliving surfaces. These communities work together to protect tooth surfaces from non-oral microbial invasion and balance the acid and alkali production (2). They can inhibit the growth of germs linked to the disease and can be influenced by the surface charge, surface energy, roughness, and topography. Biofilms also contribute to tooth decay and shorten the lifespan of dental prostheses and restoratives (3, 4). They have communication capabilities and are difficult targets for the immune system and medications due to their durability (5). Porphyromonas gingivalis is a Gram-negative, anaerobic, non-motile, and non-spore-forming bacterium (6) that can cause local infection in periodontal tissue surrounding implants, causing inflammation and systemic disease through bacteremia, persistent inflammatory cascade activation, toxins dissemination, and pathogen trafficking (7). Porphyromonas gingivalis, a keystone pathogen linked to periodontitis and Alzheimer's disease, lives in the root surfaces, gingival crevicular fluid, and gingival epithelial cells. It is found in patients with or without periodontal disease in the tonsil region, tongue, and buccal mucosa (8). It is asaccharolytic and requires iron for survival. P. gingivalis is a member of the red complex of periodontitis-related anaerobes, producing black-pigmented colonies after 3-7 days of incubation (9). P. gingivalis plasma membrane is crucial for oral pathogen growth and survival (10). It contains virulence factors like outer membrane vesicles, lipopolysaccharides, gingipains, hemolysin, and hemagglutinins. Most strains have small filamentous structures called fimbriae that proliferate outside the outer membrane, facilitating biofilm formation and bacterial adherence to the host cells (11-13). Fimbriae rely on the factors like staterin, fibrinogen, fibronectin, lactoferrin, and proline-rich proteins (11, 14). They allow P. gingivalis to adhere to the host tissues, interact with other oral bacteria, and form biofilms. They also bind to TLR2 and promote inflammatory responses such as bone resorption (15).
This pathogen expresses two distinct fimbria-molecules on its cell surface, one of which is composed of a subunit protein (named FimA or fimbrillin) encoded by the fimA gene, and termed long or long fimbriae, while the other consists of a subunit Mfa protein encoded by the mfa1 gene and termed short, minor, or Mfa fimbriae (henceforth referred to as simply long and short fimbriae)
The purpose of this study was to identify the patients with chronic gingivitis who carry the P. gingivalis fimA type I and type II genotypes.


 

Materials and Methods

Sample Collection
Fifty patients aged 11 to 70 years old who were visiting various dental centers in the heart of Al-Amarah City provided samples for periodontitis and gingival disorders, beginning on 21 November and ending on 6 February 2023. The samples from oral cavities included those with periodontitis and gingivitis of 5 mm depth of periodontal pocket.
Culture of Sample
Gingival Crevicular Fluid (GCF) samples collected from the patients were inoculated into thioglycolate broth, incubated at 37°C for 24 to 48 hours, and then inoculated on blood agar. The infected medium was then anaerobically incubated for 3 to 7 days in an anaerobic jar created by an anaerogen gas pack (16).
Identification of Bacterial Isolates
The Gram stain was conducted to identify the bacteria, and the Gram-negative ID kit (Biomerieux, France) was used for the validation of the results using the automated microbiological Vitek2 system (17).
Isolates Morphological Characterization of Bacteria
Smears from recently formed colonies were colored with Gram stain, cultured on blood agar, and examined under a microscope to observe the dye reaction with the organization and structure of the colonies. Blood agar was used to cultivate the isolates, and their colonies were characterized based on factors such as form, pigmentation, edge, and color change (18).
Molecular Assay
The obtained bacterial colonies were injected into the nutrient broth and grown for a full day or two at 37°C. DNA was extracted from the bacterial isolates using Geneaid Kit (Taiwan, Korea) as per the manufacturer’s instruction. The isolates were identified using PCR reaction by amplifying universal 16S rDNA by specific primers: F 5′-GTACAGTTGCTTCAGGACGTATC-3 and R 5′-GGTTACCTTGTTACGACTT-3′ as well as two specific primers to identify bacterial isolates P. gingivalis: F1 5′-AGGCAGCTTGCCATACTGCG-3 and R1 3′-CTGTTAGCAACTACCGATGT-5′. The PCR products were assessed by running on agarose gel.
Drug Resistance Evaluation
The antibiotics Cefoxitin (fox) 30mcg, Doxycycline (Do) 30mcg, Ciprofloxacin (CIP) 5mcg, and Nalidixic acid (NA) 30mcg were tested against Porphyromonas gingivalis using disc diffusion method.

 

 

Results

The periodontitis samples inoculated into liquid thioglycolate were assessed and diagnosed morphologically and microscopically. From 100 bacterial isolates, 35 showed significant positive growth and turbidity formation. Porphyromonas gingivalis produced black and rod-shaped colonies following 7 days incubation on blood agar plates, which are attributed to the production of hemin from erythrocytes. The result is shown in Figure 1.

Figure 1. Porphyromonas gingivalis grown on blood agar
Figure 1. Porphyromonas gingivalis grown on blood agar


Extracting DNA
Genomic DNA recovered from the isolated bacteria was identified using agarose gel electrophoresis (Figure 2).

Figure 2. The genomic DNA bands of bacterial isolates on agarose gel.
Figure 2. The genomic DNA bands of bacterial isolates on agarose gel.


Amplification using Specific Primers
The collected DNA samples from the identified microorganisms were successfully amplified by PCR using specific primers. In order to determine which primers were amplified, the PCR products were run on agarose gel. Compared to the standard molecular DNA marker, which is between 100 and 300 bp, the individual genes were differentiated by 150 bp, as shown in Figure 3.

Figure 3. PCR products (150 bp) amplified by specific primers. L: Ladder
Figure 3. PCR products (150 bp) amplified by specific primers. L: Ladder


Virulence genes: Fimbria (fim)
Two types of Universal primers were used. Using specific primers, all 26 newly identified bacteria containing fimA gene were amplified and confirmed by running on agarose gel (234 bp) (Figure 4).

Figure 4. PCR amplified fimA gene (234 bp) of Porphyromonas gingivalis using specific primers.
Figure 4. PCR amplified fimA gene (234 bp) of Porphyromonas gingivalis using specific primers.


Drug Resistance Result

Disc diffusion method showed Gram-negative anaerobic isolates resistance to all used antibiotics in vitro.


 

Discussion

The efficiency of the thioglycolate has been shown as carrier media in transporting and maintaining the vitality of Porphyromonas gingivalis from the mouth until it is delivered to the laboratory and cultured. The primary isolation media and solid development media are important in supporting the growth of these bacteria colonies which are crucial for their treatment plans (19).
In this study, each aliquot that was used for the culture was supplemented with hemin and then plated onto blood agar. Following storage of the plates anaerobically in the jar equipped with a specially designed gas pack system for seven days (20), the black-pigmented aggregates showed up. The black dye is created as a result of hemin interacting and supporting iron movement (21). This may help to explain why individuals with high iron intake are more likely to develop gingivitis.
Hemin is used by P. gingivalis as a source of iron for growth, resulting in the production of black pigments and the enlargement of plaques in the dental tissue and gums. Following the incubation time, the plates were checked for the presence of any tiny, glossy, coccobacilli, black-pigmented, and mucoid colonies (Figure 1).
Nalidixic acid is a synthetic quinolone antibiotic that acts as a bactericidal agent. About 20% of Porphyromonas gingivalis isolates were found to be resistant to Nalidixic acid, similar to previous reports. Ciprofloxacin is a fluoroquinolone antibiotic effective against most Gram-negative and Gram-positive bacteria. Cefoxitin is a second-generation cephalosporin antibiotic that protects against anaerobic bacteria. It showed resistance in 13% of Porphyromonas gingivalis isolates. Doxycycline is a broad-spectrum antibiotic belonging to the tetracycline family and fights germs by preventing their multiplying. It showed resistance to 26.6% of Porphyromonas gingivalis isolates, consistent with previous studies (20).
According to the research conducted by Ingalagi et al. (22), it is beneficial to employ several techniques to identify and quantify P. gingivalis and other periodontal infections in plaque samples (23). These colonies can be small, glossy, black-pigmented, mucoid, and with or without hemolysis.
Porphyromonas gingivalis bacterial isolates were successfully detected using specific primers that cover the upstream regions of the 16S rDNA (24). Investigation revealed that the PCR approach to identify bacteria with specific primers is unique to target bacteria but is limited to detecting the DNA of the target bacterium and is not suitable for the qualitative analysis of many unidentified bacterial species (25). Several studies have shown that using conventional culture techniques are not suitable for the obligatory anaerobes as they are rarely identified in the root canal of the patients with periapical periodontal disease (26).
The 16S rRNA gene detection by PCR helps to identify a variety of anaerobic bacteria that are resistant to growth in conventional cultures. The outcomes are comparable to the ones published before (27).
Fimbriae, major virulence factors in P. gingivalis, play a significant role in the colonization process and facilitate attachment to other oral bacteria and host cell (28). They are present in various commensal and pathogenic Bacteroides species in the human microbiota. A population-based study found that P. gingivalis has diverse occurrence patterns at the level of its virulence genes, and various factors influence its prevalence (28). PCR tests with specific primers can reliably identify the presence of P. gingivalis and essential virulence factors, such as fimA, which shows its potential use in the context of periodontal disease (29). The detection of fimA, prtC, IktA, and fap as virulence factors are substantially correlated with increasing in the frequency of target pathogens like P. gingivalis detection.
People of all ages can develop periodontitis with inflammation of the tissues; however, it is more common in those between the ages of 31 and 70 (30).


 

Conclusion

Porphyromonas gingivalis is the primary causative agent of gingivitis. It was discovered that the genes of Fimbriae, particularly the two types (Fim A and Fim B of P. gingivalis) are among the most significant factors that promote the disease of gingivitis and periodontitis, according to the molecular analysis. The study highlights the need for innovative medicines to treat oral infections due to antibiotic resistance and side effects.

 

Acknowledgment

Special thanks and deep respect go to the chairman of the Department of Biology for his kind cooperation.
 
 

Ethics approval

This study was approved by the Ethics Committee of the College of Medicine, University of Misan (Ethical code No. 198, 22/11/2022).


 

Conflicts of Interest

The authors declare no conflict of interest.


 

Authors’ contribution

Zhraa F. Faruq designed and performed the experiments and analyzed the data. Sami Kh. Jabar assisted in writing and revision of the manuscript with Dr. Mohammed Abas Abid Ali consultation.


 

Funding

This research received no specific grant from any funding agency in the public.

 
 

Type of Study: Original Research Article | Subject: Oral Microbiology
Received: 2023/10/5 | Accepted: 2024/01/10 | ePublished: 2024/01/29

References
1. Chawla N, Sarkar S. Defining "high-risk sexual behavior" in the context of substance use. J Psychosexual Health. 2019;1(1):26-31. [DOI:10.1177/2631831818822015]
2. Sanz M, Marco del Castillo A, Jepsen S, Gonzalez‐Juanatey JR, D'Aiuto F, Bouchard P, et al. Periodontitis and cardiovascular diseases: Consensus report. J Clin Periodontol. 2020;47(3):268-88. [DOI:10.1111/jcpe.13189] [PMID] [PMCID]
3. De Carvalho CC. Marine biofilms: a successful microbial strategy with economic implications. Front Mar Sci. 2018;5:126. [DOI:10.3389/fmars.2018.00126]
4. Tuck B, Watkin E, Somers A, Machuca LL. A critical review of marine biofilms on metallic materials. npj Mater Degrad. 2022;6(1):25. [DOI:10.1038/s41529-022-00234-4]
5. Holmer J. Periodontal disease and cognitive disorders. Karolinska Institutet (Sweden); 2022. Available from: [https://openarchive.ki.se/xmlui/handle/10616/47885]
6. Mohanty R, Asopa SJ, Joseph MD, Singh B, Rajguru JP, Saidath K, et al. Red complex: Polymicrobial conglomerate in oral flora: A review. J Family Med Prim Care. 2019;8(11):3480. [DOI:10.4103/jfmpc.jfmpc_759_19] [PMID] [PMCID]
7. Damgaard C, Danielsen AK, Enevold C, Massarenti L, Nielsen CH, Holmstrup P, et al. Porphyromonas gingivalis in saliva associates with chronic and aggressive periodontitis. J Oral Microbiol. 2019;11(1):1653123. [DOI:10.1080/20002297.2019.1653123] [PMID] [PMCID]
8. Ryder MI. Porphyromonas gingivalis and Alzheimer disease: Recent findings and potential therapies. J Periodontol. 2020;91:S45-9. [DOI:10.1002/JPER.20-0104] [PMID] [PMCID]
9. Endres BT, Basseres E, Citron DM, Tyrrell KL, Begum K, Lancaster C, et al. Fusobacteria behaving badly: Masquerading strains of strictly anaerobic Escherichia coli misidentified due to the deletion of the hemB gene. Anaerobe. 2023;79:102682. [DOI:10.1016/j.anaerobe.2022.102682] [PMID]
10. Chen WA, Dou Y, Fletcher HM, Boskovic DS. Local and Systemic Effects of Porphyromonas gingivalis Infection. Microorganisms. 2023;11(2):470. [DOI:10.3390/microorganisms11020470] [PMID] [PMCID]
11. Xu W, Zhou W, Wang H, Liang S. Roles of Porphyromonas gingivalis and its virulence factors in periodontitis. Adv Protein Chem Struct Biol. 2020;120:45-84. [DOI:10.1016/bs.apcsb.2019.12.001] [PMID] [PMCID]
12. Hasegawa Y, Nagano K. Porphyromonas gingivalis FimA and Mfa1 fimbriae: Current insights on localization, function, biogenesis, and genotype. Jpn Dent Sci Rev. 2021;57:190-200. [DOI:10.1016/j.jdsr.2021.09.003] [PMID] [PMCID]
13. Jia L, Han N, Du J, Guo L, Luo Z, Liu Y. Pathogenesis of important virulence factors of Porphyromonas gingivalis via toll-like receptors. Front Cell Infect Microbiol. 2019;9:262. [DOI:10.3389/fcimb.2019.00262] [PMID] [PMCID]
14. Lamont RJ, Jenkinson HF. Subgingival colonization by Porphyromonas gingivalis. Oral Microbiol Immunol: Mini‐Rev. 2000;15(6):341-9. [DOI:10.1034/j.1399-302x.2000.150601.x] [PMID]
15. Silva LM, Doyle AD, Greenwell-Wild T, Dutzan N, Tran CL, Abusleme L, et al. Fibrin is a critical regulator of neutrophil effector function at the oral mucosal barrier. Science. 2021;374(6575):eabl5450. [DOI:10.1126/science.abl5450] [PMID]
16. Chetan GB, Reddy M. Comparative evaluation of four office reconditioning methods for orthodontic stainless steel brackets on shear bond strength-an in vitro study. Ann Essences Dent. 2011;3(1):6-13. [DOI:10.5368/aedj.2011.3.1.1.2]
17. Skucaite N, Peciuliene V, Vitkauskiene A, Machiulskiene V. Susceptibility of endodontic pathogens to antibiotics in patients with symptomatic apical periodontitis. J Endod. 2010;36(10):1611-6. [DOI:10.1016/j.joen.2010.04.009] [PMID]
18. Yoshimura F, Murakami Y, Nishikawa K, Hasegawa Y, Kawaminami S. Surface components of Porphyromonas gingivalis. J Periodontal Res. 2009;44(1):1-12. [DOI:10.1111/j.1600-0765.2008.01135.x] [PMID]
19. Deppe H, Reitberger J, Behr AV, Vitanova K, Lange R, Wantia N, et al. Oral bacteria in infective endocarditis requiring surgery: a retrospective analysis of 134 patients. Clin Oral Investig. 2022;26(7):4977-85. [DOI:10.1007/s00784-022-04465-2] [PMID] [PMCID]
20. Chitsazha R, Faramarzi M, Sadighi M, Pourabbas R, Pourhajibagher M, Firouzi N, et al. Evaluation of antibacterial effect of concentrated growth factor on Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis. J Family Med Prim Care. 2022;11(6):2865-9. [DOI:10.4103/jfmpc.jfmpc_2065_21] [PMID] [PMCID]
21. Parmar AS, Panwar AS. Antimicrobial Study of Chitosan-Based Crosslinked Hydrogel Against Staphylococcus aureus, Porphyromonas gingivalis, Pseudomonas aeruginosa, and Streptococcus mutans. Curr Trends Biotechnol Pharm. 2023;17(Supplement 3A):1170-83.
22. Ingalagi P, Bhat KG, Kulkarni RD, Kotrashetti VS, Kumbar V, Kugaji M. Detection and comparison of prevalence of Porphyromonas gingivalis through culture and Real Time-polymerase chain reaction in subgingival plaque samples of chronic periodontitis and healthy individuals. J Oral Maxillofac Pathol. 2022;26(2):288. [DOI:10.4103/jomfp.jomfp_163_21] [PMID] [PMCID]
23. Gan N, Qin W, Zhang C, Jiao T. One-step in situ deposition of phytic acid-metal coordination complexes for combined Porphyromonas gingivalis infection prevention and osteogenic induction. J Mater Chem B. 2022;10(22):4293-305. [DOI:10.1039/D2TB00446A] [PMID]
24. Noguchi N, Noiri Y, Narimatsu M, Ebisu S. Identification and localization of extraradicular biofilm-forming bacteria associated with refractory endodontic pathogens. Appl Environ Microbiol. 2005;71(12):8738-43. [DOI:10.1128/AEM.71.12.8738-8743.2005] [PMID] [PMCID]
25. Lan C, Chen S, Jiang S, Lei H, Cai Z, Huang X. Different expression patterns of inflammatory cytokines induced by lipopolysaccharides from Escherichia coli or Porphyromonas gingivalis in human dental pulp stem cells. BMC Oral Health. 2022;22(1):121. [DOI:10.1186/s12903-022-02161-x] [PMID] [PMCID]
26. Sugiyama N, Uehara O, Morikawa T, Paudel D, Ebata K, Hiraki D, et al. Gut flora alterations due to lipopolysaccharide derived from Porphyromonas gingivalis. Odontology. 2022;110(4):673-81. [DOI:10.1007/s10266-022-00703-x] [PMID]
27. Rolim JP. Estudos dos efeitos da terapia fotodinâmica antimicrobiana na viabilidade e na expressão gênica de S. mutans em biofilmes e lesões de cárie dentinária (Studies of the effects photodynamic therapy antimicrobial and gene expression of S. Mutans biofilms and caries dentin). Universidade Federal do Ceará. Faculdade de Farmácia, Odontologia e Enfermagem, Fortaleza, 2012. Available from: [https://repositorio.ufc.br/handle/riufc/4819]
28. Meyer HL, Abdelbary MM, Buhl EM, Kuppe C, Conrads G. Exploring the genetic and functional diversity of Porphyromonas gingivalis long fimbriae. Mol Oral Microbiol. 2023;38(5):408-23. [DOI:10.1111/omi.12433] [PMID]
29. Zou P, Li P, Liu J, Cao P, Luan Q. Direct current exerts electricidal and bioelectric effects on Porphyromonas gingivalis biofilms partially via promoting oxidative stress and antibiotic transport. J Microbiol. 2022;60(1):70-8. [DOI:10.1007/s12275-022-1238-5] [PMID]
30. Moreno S, Jaramillo A, Parra B, Botero JE, Contreras A. Porphyromonas gingivalis Fim-A genotype distribution among Colombians. Colombia Médica. 2015;46(3):122-7. [DOI:10.25100/cm.v46i3.1535] [PMID] [PMCID]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Iranian Journal of Medical Microbiology

Designed & Developed by : Yektaweb | Publisher: Farname Inc